Ekinci, who is also Director of the Australian Centre for Accelerating Diabetes Innovations (ACADI), said the technology has the potential to improve health equity and deliver economic benefits for Australia’s healthcare system.
“Diabetes-related foot disease places a significant burden on individuals and the Australian health system, costing an estimated $875 million every year,” she said.
“By enabling earlier identification of ulcers at risk of delayed wound healing, THERMUL has the potential to improve access to timely care and reduce complications.”
Senior research fellow at Bolton Clarke, Dr Rajna Ogrin, said people in regional, rural and remote areas living with diabetes and receiving care at home, or through outreach services, may not have timely access to specialist diabetes foot services.
"A portable, non-contact tool like THERMUL has the potential to bring specialist-level decision support closer to where people live and receive care," she said.
Seed funding from ACADI enabled the research team to develop the prototype.
The research team recently received $490,539 through Australia’s Economic Accelerator program and $50,000 from the University of Melbourne’s Proof of Concept Fund.
They will use this funding to validate the technology across a range of healthcare settings, including metropolitan, regional and remote services, and to further improve the predictive model.